Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Desautels

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Annals of Palliative Medicine|September 11, 2019
Role of bone-modifying agents in advanced cancerDanielle N Desautels, Craig H Harlos, Katarzyna J Jerzak
Expert Opinion on Pharmacotherapy|August 20, 2016
An update on adjuvant systemic therapy for elderly patients with early breast cancerKatarzyna J Jerzak, Danielle N Desautels, Kathleen I Pritchard
European Journal of Cancer (Oxford, England : 1990)|October 25, 2016
Do aromatase inhibitors increase cardiovascular risk? Piecing together the evidenceDanielle N Desautels, Phillip S Blanchette, Kathleen I Pritchard
Canadian Journal of Surgery. Journal Canadien De Chirurgie|December 1, 1991
[A utilization review program of cefoxitin]N Desautels, A Fillion, Y Girouard, et al.
Gynecologic Oncology|July 11, 2017
Is hormonal therapy effective in advanced endometrial cancer? A systematic review and meta-analysisJosee-Lyne Ethier, Danielle N Desautels, Eitan Amir, et al.
Critical Ultrasound Journal|April 9, 2015
Case report: an unrecognized etiology of transient gallbladder pain in heart failure diagnosed with internist-performed point-of-care ultrasoundChristine N Desautels, David M Tierney, Federico Rossi, et al.
Expert Opinion on Pharmacotherapy|March 31, 2018
An update on treatment for post-menopausal metastatic breast cancer in elderly patientsInes B Menjak, Katarzyna J Jerzak, Danielle N Desautels, et al.
American Journal of Clinical Oncology|December 4, 2023
Long-term Survival Among Patients With De Novo Human Epidermal Growth Receptor 2-Positive Metastatic Breast Cancer in ManitobaErin N McAndrew, Jeffrey Graham, Brenden Dufault, et al.
Gynecologic Oncology|February 23, 2017
Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysisJosee-Lyne Ethier, Danielle N Desautels, Arnoud J Templeton, et al.
Oncology (Williston Park, N.Y.)|November 27, 2018
Bone-Targeted Therapy in Early Breast CancerKatarzyna J Jerzak, Jacques Raphael, Danielle N Desautels, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Annals of Palliative Medicine|September 11, 2019
Role of bone-modifying agents in advanced cancerDanielle N Desautels, Craig H Harlos, Katarzyna J Jerzak
Expert Opinion on Pharmacotherapy|August 20, 2016
An update on adjuvant systemic therapy for elderly patients with early breast cancerKatarzyna J Jerzak, Danielle N Desautels, Kathleen I Pritchard
European Journal of Cancer (Oxford, England : 1990)|October 25, 2016
Do aromatase inhibitors increase cardiovascular risk? Piecing together the evidenceDanielle N Desautels, Phillip S Blanchette, Kathleen I Pritchard
Canadian Journal of Surgery. Journal Canadien De Chirurgie|December 1, 1991
[A utilization review program of cefoxitin]N Desautels, A Fillion, Y Girouard, et al.
Gynecologic Oncology|July 11, 2017
Is hormonal therapy effective in advanced endometrial cancer? A systematic review and meta-analysisJosee-Lyne Ethier, Danielle N Desautels, Eitan Amir, et al.
Critical Ultrasound Journal|April 9, 2015
Case report: an unrecognized etiology of transient gallbladder pain in heart failure diagnosed with internist-performed point-of-care ultrasoundChristine N Desautels, David M Tierney, Federico Rossi, et al.
Expert Opinion on Pharmacotherapy|March 31, 2018
An update on treatment for post-menopausal metastatic breast cancer in elderly patientsInes B Menjak, Katarzyna J Jerzak, Danielle N Desautels, et al.
American Journal of Clinical Oncology|December 4, 2023
Long-term Survival Among Patients With De Novo Human Epidermal Growth Receptor 2-Positive Metastatic Breast Cancer in ManitobaErin N McAndrew, Jeffrey Graham, Brenden Dufault, et al.
Gynecologic Oncology|February 23, 2017
Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysisJosee-Lyne Ethier, Danielle N Desautels, Arnoud J Templeton, et al.
Oncology (Williston Park, N.Y.)|November 27, 2018
Bone-Targeted Therapy in Early Breast CancerKatarzyna J Jerzak, Jacques Raphael, Danielle N Desautels, et al.
Pageof 2